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GeneChip microarray analysisThe molecular mechanism responsible for cell fate after mitotic slippage is unclear. We investigated the
postmitotic effects of different mitotic aberrations (Ohashi et al. [1]), misaligned chromosomes produced by
CENP-E siRNA (siCENP-E), and monopolar spindles resulting from Eg5 siRNA (siEg5) (Miki et al. [2]). To deter-
mine which signaling pathways contribute to the postmitotic effect of siCENP-E in the presence of siBubR1
(siCENP-E + siBubR1) compared with siEg5+ siBubR1, we performed comprehensive gene expression analysis
usingmicroarray comparisons [1]. Themicroarray data have been deposited in NCBI's Gene Expression Omnibus
(GEO) and are accessible through GEO Series accession number GSE67905.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Speciﬁcationsrganism/cell line/tissue Homo sapiens/HeLa/cervical cancer
x Female
quencer or array type Affymetrix Human Genome U133 Plus 2.0 Array
(Affymetrix Inc., CA, USA)
ata format Raw: CEL ﬁles, normalized data: SOFT, MINIML and
TXT
xperimental factors siBubR1 + siCENP-E-treated cells vs. siBubR1 +
siEg5-treated cells vs. siBubR1-treated cells.
siNS-treated cells were used as a negative control.xperimental features A comprehensive gene expression analysis by
microarray comparisons was performed comparing
siBubR1 + siCENP-E-treated, siBubR1 +
siEg5-treated, and siBubR1-treated cells.onsent Not necessary, HeLa cells were obtained from ATCC.
mple source location Fujisawa, Kanagawa, JapanSa1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67905. This is an open access article under2. Experimental design, materials and methods
2.1. Cell cultures
HeLa cells, purchased fromAmerican Type Culture Collection (ATCC;
Manassas, VA, USA),were cultured in Dulbecco'smodiﬁed Eagle'smedi-
um (DMEM) supplemented with 10% FBS.
2.2. Transfection of siRNA oligonucleotides
Weinvestigated thepostmitotic effects of differentmitotic aberrations [1],
misaligned chrmosoms by siCENP-E andmonopolar spindles by siEg5 [2].
siRNA oligonucleotides targeting CENP-E (M-003252-02), Eg5 (M-
003317-01), and BubR1 (M-004101-02) were obtained fromDharmacon
(SMART pools, Dharmacon, Lafayette, CO, USA). The siTrio negative
control (B-Bridge International, Inc., Mountain View, CA, USA) was used
as a non-silencing (NS) siRNA (siNS). Twenty-ﬁve nanomoles of pooled
siRNA per genewere used for double knockdown (total siRNA concentra-
tion, 50 nM). siRNA transfection was performed as described previously
[3]. Transfection of siRNA oligonucleotides was performed with
Dharmafect (Dharmacon) in 6-well plates according to the
manufacturer's speciﬁcations. Seventy-two hours after transfection,
the cells were collected for RNA preparation for GeneChip microarray
analysis.
2.3. GeneChip microarray analysis
To determine which signaling pathways contribute to the
postmitotic effect of siCENP-E + siBubR1 compared with siEg5 +the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Schematic presentation of microarray comparisons in this study.
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microarray comprisons (Fig. 1).
Total RNAs were extracted using the RNeasy Miniprep kit (Qiagen,
Valencia, CA, USA) according to the manufacturer's protocol. Prepara-
tion of cDNAs and cRNAs, hybridization, and microarray scanning
were performed according to the manufacturer's protocols (Affymetrix
Inc., CA, USA). Biotinylated cRNAs were hybridized to Affymetrix
Human Genome U133 Plus 2.0 Array. Microarray Analysis Suite 5.0
(MAS5; Affymetrix) was used to quantify microarray signals, and the
intensities were normalized to the median expression level by setting
the median intensity to 1.0 using the GeneSpring software package
(Agilent Technology, Santa Clara, CA, USA). Differentially expressed
genes were identiﬁed with a fold change of N2.0. Probe sets with absentcall in all samples for comparison were ﬁltered out. In addition, intensity
ﬁltering was applied, with the criterion set to 0.5. The microarray data
have been deposited in NCBI's Gene Expression Omnibus (GEO) and are
accessible through GEO Series accession number GSE67905.
3. Discussion
In this study, we acquired microarray gene expression proﬁles
for siBubR1 + siCENP-E-treated, siBubR1 + siEg5-treated, and
siBubR1 -treated cells. These expression data would be valuable
for understanding the postmitotic effects of aneuploidy as well as
polyploidy.
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